Fulcrum Therapeutics
FULC
#6285
Rank
NZ$1.45 B
Marketcap
NZ$22.02
Share price
-7.25%
Change (1 day)
198.77%
Change (1 year)

Earnings for Fulcrum Therapeutics (FULC)

Earnings in 2025 (TTM): -NZ$0.15 Billion

According to Fulcrum Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$34.12 Million, an increase over its 2023 earnings that were of -NZ$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fulcrum Therapeutics from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.15 Billion312.32%
2024 -NZ$34.12 Million-82.08%
2023 -NZ$0.2 Billion-1.31%
2022 -NZ$0.2 Billion38.34%
2021 -NZ$0.14 Billion13.19%
2020 -NZ$0.13 Billion-14.97%
2019 -NZ$0.15 Billion151.41%
2018 -NZ$57.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.26 Billion 81.61%๐Ÿ‡บ๐Ÿ‡ธ USA